iBio IBIO
NASDAQ IBIO
$1.12 +0.00 (+0.45%)
As of: Oct 2, 2026 · 1:08 PM EDT

iBio (IBIO) Return on Assets [ROA] (2011 - 2026)

Updated

iBio's Return on Assets [ROA] came in at -35.73% for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 51.18 percentage points from -86.91% a year earlier and up 1.02 percentage points from the prior quarter.

Analysis

iBio (IBIO) Return on Assets [ROA] (2011 - 2026) Analysis & Trends

For FY2026 (ended Jun 30, 2026), iBio's Return on Assets [ROA] was -54.04%, up 16.75 percentage points from FY2025.

  • Return on Assets [ROA] has increased in each of the last three fiscal years, though with a five-year change of -34.79 percentage points (FY2021 to FY2026).
  • Going back by fiscal year, Return on Assets [ROA] was -70.79% in FY2025 (+0.43 pp), -71.22% in FY2024 (+21.24 pp), -92.47% in FY2023 (-51.63 pp) and -40.84% in FY2022 (-21.58 pp).
  • The fiscal Q4 2026 figure represents the highest quarterly Return on Assets [ROA] since fiscal Q3 2022.
  • Year-over-year, Return on Assets [ROA] has increased for four consecutive quarters, with an average year-over-year change of +21.34 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q3 2024 (a gain of 103.06 percentage points), and the weakest in fiscal Q3 2023 (a drop of 130.69 percentage points).
  • Business Quant data shows IBIO's Return on Assets [ROA] at -36.75% (Q3 2026), -38.49% (Q2 2026) and -46.05% (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 iBio 122.79 Mn 122.79 Mn - -35.73%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -35.73%
Mar 31, 2026 -36.75%
Dec 31, 2025 -38.49%
Sep 30, 2025 -46.05%
Jun 30, 2025 -86.91%
Mar 31, 2025 -102.90%
Dec 31, 2024 -83.54%
Sep 30, 2024 -86.95%
Jun 30, 2024 -63.15%
Mar 31, 2024 -55.03%
Dec 31, 2023 -76.11%
Sep 30, 2023 -133.42%
Jun 30, 2023 -151.90%
Mar 31, 2023 -158.09%
Dec 31, 2022 -118.99%
Sep 30, 2022 -64.68%
Jun 30, 2022 -46.84%
Mar 31, 2022 -27.41%
Dec 31, 2021 -21.03%
Sep 30, 2021 -16.94%
API Access

iBio Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IBIO&period=max&api_key=YOUR_API_KEY